ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş. Özel Durum Açıklaması (Genel) 12 Kasım 2026

As Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş., we hereby present to our investors the developments recorded in our Company's operational performance, growth indicators and profitability structure within the framework of the financial results for the first nine months of 2026.

In the first nine months of 2026:

·         Our revenue reached TRY 809.9 million, representing an increase of approximately 19.3% compared to the same period of the previous year.

·         Our gross profit reached TRY 416.9 million, recording an increase of approximately 65.2% compared to the same period of the previous year.

·         Our operating profit increased to TRY 194.6 million, representing a strong increase of approximately 143.7% compared to the same period of the previous year.

·         EBITDA amounted to TRY 260.5 million, recording an increase of approximately 86% compared to the same period of the previous year.

·         Our net profit for the period amounted to TRY 60.5 million, representing an increase of approximately 82.8% compared to the same period of the previous year.

·         Our gross profit margin stood at 51.5%, operating profit margin at 24.0%, EBITDA margin at 32.2%, and net profit margin at 7.5%.

·         As of 30 September 2026, our total assets reached TRY 902.1 million, while our shareholders' equity amounted to approximately TRY 559.7 million.

These financial results demonstrate not only our Company's growth performance but also a significant improvement in its profitability structure and operational efficiency.

In particular, the increases in gross profit, operating profit and EBITDA indicate improvements in efficiency, cost management and our capacity to generate added value in our core business activities. The approximately 144% increase in operating profit and 86% increase in EBITDA are significant indicators of the strengthening of our operational performance.

The results achieved in the first nine months of 2026 demonstrate that our Company is focused not only on increasing sales volume but also on enhancing the quality of growth, operational efficiency and sustainable profitability capacity.

The increase in our shareholders' equity to TRY 559.7 million is also an important development contributing to the strengthening of our Company's financial structure.

Our Company continues its efforts with determination to expand its value-added product and service portfolio, increase production capacity, capitalize on opportunities in domestic and international markets, and strengthen its long-term revenue-generating potential.

In this regard, through the contribution of our existing operational infrastructure, products and services under development, production capabilities and new business opportunities, our Company aims to further strengthen its sustainable growth, operational efficiency and profitability capacity in the coming periods.

Respectfully submitted for the information of our investors.

The English translation of this disclosure is attached hereto. In case of any discrepancy between the Turkish and English versions of the disclosure, the Turkish version shall prevail.